Breaking News Instant updates and real-time market news.

FB

Facebook

$207.33

0.43 (0.21%)

, TWTR

Twitter

$44.49

-0.775 (-1.71%)

13:27
07/14/18
07/14
13:27
07/14/18
13:27

Facebook, Alphabet to testify at U.S. House hearing, Reuters reports

The U.S. House Judiciary Committee will hold a hearing on Tuesday to take testimony from Facebook (FB), Alphabet (GOOG; GOOGL) YouTube unit and Twitter (TWTR) on whether social media companies are filtering content for political reasons, according to Reuters, citing the committee chairman. Reference Link

FB

Facebook

$207.33

0.43 (0.21%)

TWTR

Twitter

$44.49

-0.775 (-1.71%)

GOOG

Alphabet

$1,188.81

4.94 (0.42%)

GOOGL

Alphabet Class A

$1,204.34

2.43 (0.20%)

  • 17

    Jul

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 27

    Jul

  • 08

    Aug

  • 28

    Oct

FB Facebook
$207.33

0.43 (0.21%)

07/12/18
ADAM
07/12/18
NO CHANGE
Target $240
ADAM
Buy
Privacy concerns at Facebook linger, but Canaccord says 'constructive' on shares
Canaccord analyst Michael Graham maintained a Buy rating on Facebook (FB) shares ahead of the company's quarterly earnings, telling investors in a research note that he is the most constructive among the "FANG" stocks on Facebook and Amazon (AMZN), although he adds that the FANG stocks are trading at a multiple that's low by historical standards but high compared to the past eight years. Looking ahead, Graham says slowing ad load growth places greater burden for revenue growth on ad pricing, and data and privacy concerns will linger and may intensify, but he still sees a very constructive case for fundamentals and estimates for the rest of the year and find the valuation reasonable relative to growth. The analyst says he is "comfortable" with his $240 price target, which is based on 26x 2019 EPS.
07/13/18
LEHM
07/13/18
NO CHANGE
Target $226
LEHM
Overweight
Facebook price target raised to $226 from $190 at Barclays
Barclays analyst Ross Sandler maintained an Overweight rating on Facebook and raised his price target to $226 from $190, telling investors that he sees an in-line Q2 with high expectations into the print, which he believes is largely priced in. Looking ahead, Sandler says the narrative around Stories ads could be a catalyst this year and beyond, and that Q2 should see MAU and DAU "leakage" in Europe from GDPR, which he views as a non-event, but could weigh on shares in the short-term.
07/13/18
LEHM
07/13/18
NO CHANGE
Target $24
LEHM
Underweight
Twitter valuation 'the primary factor that gives us pause,' says Barclays
Barclays analyst Ross Sandler maintained an Underweight rating and $24 price target on Twitter (TWTR) ahead of its quarterly earnings, telling investors in a research note that while he thinks the company will report "solid" revenue and EBITDA, the company, like Facebook (FB) and Snap (SNAP), will have issues with MAU around GDPR and account clean up. However, he says the company is executing well on its turnaround, checks are pointing to advertisers allocating more to Twitter, which should support mid-20%s O+O ad revenue growth, and says valuation remains the major factor "that gives us pause."
07/13/18
JEFF
07/13/18
NO CHANGE
Target $240
JEFF
Buy
Facebook price target raised to $240 from $215 at Jefferies
Jefferies analyst Brent Thill raised his price target for Facebook (FB) shares to $240 from $215 ahead of the Q2 reporting season for the Internet space. The social media giant closed yesterday up 2% to $206.98. Amazon.com (AMZN), Facebook and Google (GOOGL) are the analyst's top large-cap picks into the earnings season. Expedia (EXPE) is Thill's top value play while IAC (IAC) and GoDaddy (GDDY) are his favorite names among smaller caps. Facebook continues to be the best return on investment for advertisers as Instagram shows continued strength and more ad opportunities are being added, Thill tells investors in a research note on the Internet space. He sees earnings per share of $10-plus "on the horizon." A 25-30 times multiple off that yields a stock price of $250-$300 for Facebook, the analyst points out. Thill keeps a Buy rating on the name.
TWTR Twitter
$44.49

-0.775 (-1.71%)

07/12/18
MKMP
07/12/18
NO CHANGE
Target $43
MKMP
Buy
Twitter's improvement in AI is 'important', says MKM Partners
MKM Partners analyst Rob Sanderson kept his Buy rating and $43 price target on Twitter, saying that despite the 6% pullback in the stock price this week, suspending accounts of "bad actors" and addressing "rampant bot use on the network" is a positive. The analyst notes that while the information quality efforts have been ongoing for some time, they are now showing positive results, adding the commentary from the company's CFO also suggests "limited impact" to reporting metrics from those measures. Sanderson further states that Twitter's use of Machine Learning and AI are important in making the network content more safe, authentic, and relevant while addressing its perception of being too cluttered and hard to use in the mass market.
07/12/18
GSCO
07/12/18
NO CHANGE
Target $55
GSCO
Buy
Twitter price target raised to $55 from $40 at Goldman Sachs
Goldman Sachs analyst Heath Terry raised his price target on Twitter to $55 and kept his Buy rating, saying that despite the run-up in the stock price year-to-date, consensus expectation on the company continue to underestimate its drive to increase and better monetize user engagement. Terry further notes that the company is also showing significant operating expense leverage, while adding that advertiser checks and 3rd party traffic data checks do not suggest that Twitter's information quality initiative of recent days had much impact on engagement and will actually be "net positive". The analyst contends that despite trading at a higher valuation on enterprise value to expected FY19 EBITDA, its growth rate justifies the premium.
07/12/18
07/12/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS CUTS NETFLIX TO NEUTRAL: UBS analyst Eric Sheridan downgraded Netflix (NFLX) to Neutral while raising his price target for the shares to $425 from $375. The stock has appreciated 35% since the Q1 earnings report and 117% year-to-date, Sheridan told investors in a research note. The analyst said he believes the shares already reflect a 40 times GAAP EBITDA multiple on 2022 estimates. In addition to valuation, Sheridan does not see the "pronounced upside" to Monday's Q2 results relative to prior quarters. B RILEY FBR ALSO CAUTIOUS ON NETFLIX: Searches for new Netflix shows slowed to flattish versus the year-ago period, and year-over-year growth in global searches for the term "Netflix" also slowed somewhat, B. Riley FBR analyst Barton Crockett told investors in a research note. Amid heightened expectations, the analyst finds the flattish search volume as "potentially cautionary." The analyst reiterated a Neutral rating on Netflix with a $313 price target. After the cautious notes, Netflix is down almost 2% in late morning trading. GOLDMAN SACHS RAISES TWITTER TARGET: Goldman Sachs analyst Heath Terry raised his price target on Twitter (TWTR) to $55 and kept his Buy rating, saying that despite the run-up in the stock price year-to-date, consensus expectation on the company continue to underestimate its drive to increase and better monetize user engagement. The analyst contended that despite trading at a higher valuation on enterprise value to expected FY19 EBITDA, its growth rate justifies the premium. BROADCOM DOWNGRADED FOLLOWING CA DEAL: B. Riley FBR analyst Craig Ellis downgraded Broadcom (AVGO) to Neutral and lowered his price target for the shares to $245 from $308 following the company's acquisition of CA Technologies (CA). The deal adds strategic and operational uncertainty, Ellis tells investors in a research note. RBC Capital analyst Amit Daryanani also downgraded Broadcom, to Outperform from Top Pick, and lowered his price target to $300 from $330 after its acquisition of CA Technologies. The analyst noted that the deal places Broadcom "in the penalty box from a valuation expansion perspective", stating that while it offers "strong accretion" and provides a "foundation to perhaps scale its model beyond traditional semiconductor sector", it is also entering a market where it has limited history, likely tempering investor optimism on the stock going forward. Broadcom shares were also downgraded by analysts at Longbow, Macquarie and B. Riley FBR following last night's deal announcement.
GOOG Alphabet
$1,188.81

4.94 (0.42%)

07/13/18
LEHM
07/13/18
NO CHANGE
Target $1350
LEHM
Overweight
Alphabet price target raised to $1,350 from $1,250 at Barclays
Barclays analyst Ross Sandler reiterated an Overweight rating and raised his price target to $1,350, telling investors in a research note that he would add to positions into Q2, "full stop." Sandler says the recipe for upside is simple, "beat consensus for sites revenue, TAC and operating margin," and he believes this trifecta may happen in Q2 against a muted sentiment backdrop, causing shares to respond positively. He continues to view the risk/reward as attractive.
07/11/18
07/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOGL, GOOG), Facebook (FB), and Spotify (SPOT) were initiated with a Buy at Nomura Instinet while Twitter (TWTR) was initiated with a Reduce. 2. AMC Entertainment (AMC) and Cinemark (CNK) were initiated with an Outperform at Imperial Capital. 3. Keurig Dr Pepper (KDP) initiated with a Hold at Stifel. 4. Myers Industries (MYE) initiated with a Neutral at Baird and JPMorgan. 5. TPG Pace Energy (TPGE) initiated with an Outperform at Northland. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/18
ADAM
07/12/18
NO CHANGE
Target $1050
ADAM
Hold
Alphabet 'fairly valued' ahead of Q2 earnings, says Canaccord
Canaccord analyst Michael Graham said Alphabet is fairly valued ahead of its Q2 earnings report, telling investors in a research note that he believes the company will report "solid" top line performance and is comfortable with his estimate for 26% core Properties revenue growth. He sees core revenue growth staying "comfortable" above 20%, but thinks Alphabet will continue to underperform the FANG complex as gross margin contraction leads to slower EPS growth. With the multiple at a historically "full" level, Graham thinks stock appreciation may be limited. Graham has a Hold rating and $1,050 price target on Alphabet shares.
GOOGL Alphabet Class A
$1,204.34

2.43 (0.20%)

07/11/18
07/11/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MCDONALD'S CUT TO NEUTRAL: Cleveland Research analyst Steven Gojak downgraded McDonald's (MCD) to Neutral from Buy after his industry checks led him to believe that its comparable sale results in the second half will trend more in-line with consensus expectations. Gojak, who is still modeling Q2 U.S. comp sales growth of 3.7% for McDonald's, which is above the 3.1% consensus growth view, lowered his 2018 U.S. comp estimate to 3.2% from 3.4%, compared to the consensus of 3.1% growth. McDonald's is down 1% in midday trading. NOMURA INITIATES INTERNET SECTOR: Nomura Instinet initiated coverage on the Americas Internet sector. Nomura Instinet initiated Alphabet Class A (GOOGL), Facebook (FB), and Spotify (SPOT) with Buy ratings, and added that Alphabet and Facebook were the best positioned in this newly regulated industry. It initiated Twitter (TWTR) with a Reduce rating, saying that while it is a "stable long-term asset that has something for everyone," the firm believes the market is pricing in "a significant advertising reacceleration that implies a shift in ad spend," while the firm expects "stability instead of a reacceleration of growth." CREDIT SUISSE POSITIVE ON VERIZON, NEGATIVE ON AT&T: Credit Suisse analyst Douglas Mitchelson initiated Verizon (VZ) with an Outperform rating and a price target of $58. The analyst believes Verizon should benefit from its "major $10B cost savings plan, stable capex spending, record low churn, and the benefit of tax reform." Mitchelson also initiated AT&T (T) with an Underperform rating and a price target of $29. Mitchelson said that AT&T will require greater scale and a shift to global direct-to-consumer distribution, stating that the elevated execution risk under its ownership structure and its wireless business look mature with little chance for stabilization in spite of the coming 5G technology. DISNEY VALUATION NOT COMPELLING: Credit Suisse analyst Douglas Mitchelson initiated Disney (DIS) with a Neutral rating and a price target of $114. The analyst noted that the company is "the best positioned traditional media company", but believes the Street has not sufficiently discounted the costs associated with Disney's push into direct-to-consumer streaming services, adding that FY19 will be extra challenging because of high film comps and major theme park project launches.

TODAY'S FREE FLY STORIES

AVID

Avid

$5.79

0.19 (3.39%)

04:59
11/15/18
11/15
04:59
11/15/18
04:59
Recommendations
Avid analyst commentary  »

Avid price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIN

Linde plc

$153.45

-3.35 (-2.14%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Initiation
Linde plc initiated  »

Linde plc initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$209.85

2.02 (0.97%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
MarketAxess management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

04:55
11/15/18
11/15
04:55
11/15/18
04:55
General news
Breaking General news story  »

Minneapolis Federal…

04:55
11/15/18
11/15
04:55
11/15/18
04:55
General news
Breaking General news story  »

Week of 11/9 EIA Natural…

QLYS

Qualys

$71.92

-0.09 (-0.12%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Qualys to hold analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 09

    Jan

PFG

Principal Financial

$48.29

-0.71 (-1.45%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Principal Financial to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 03

    Dec

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
RBC Capital telecom/data centers analyst to hold a group luncheon »

Telecom & Data…

CNHI

CNH Industrial

$9.81

-0.03 (-0.30%)

, HSY

Hershey

$107.94

-1.24 (-1.14%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
BlackLine to hold a summit »

In The Black 2018:…

CNHI

CNH Industrial

$9.81

-0.03 (-0.30%)

HSY

Hershey

$107.94

-1.24 (-1.14%)

TAP

Molson Coors

$64.75

0.24 (0.37%)

ZEN

Zendesk

$53.12

0.56 (1.07%)

ETP

Energy Transfer Partners

$0.00

(0.00%)

G

Genpact

$29.11

-0.73 (-2.45%)

SAP

SAP

$103.86

0.11 (0.11%)

BL

BlackLine

$38.78

-1.79 (-4.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 26

    Nov

  • 02

    Dec

  • 06

    Dec

  • 06

    Dec

  • 12

    Dec

  • 13

    Dec

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
RBC Capital software analysts to hold a group luncheon »

Software Analysts Hedberg…

MGM

MGM Resorts

$25.94

0.2 (0.78%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
MGM Resorts management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 19

    Nov

AWI

Armstrong World

$66.00

-1.94 (-2.86%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Armstrong World management to meet with SunTrust »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

SIRI

Sirius XM

$6.25

0.1 (1.63%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Sirius XM management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

04:55
11/15/18
11/15
04:55
11/15/18
04:55
General news
Retail Sales less autos to be reported at 08:30 »

October Retail Sales less…

GNBC

Green Bancorp

$18.18

-0.25 (-1.36%)

, VBTX

Veritex

$22.94

-0.24 (-1.04%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Veritex to host special shareholder meeting »

Special Shareholder…

GNBC

Green Bancorp

$18.18

-0.25 (-1.36%)

VBTX

Veritex

$22.94

-0.24 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
CLSA to hold a forum »

21st India Forum will be…

CTSO

CytoSorbents

$9.05

-0.5 (-5.24%)

, KZR

Kezar Life Sciences

$25.47

-0.75 (-2.86%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Jefferies to hold a conference »

London Healthcare…

CTSO

CytoSorbents

$9.05

-0.5 (-5.24%)

KZR

Kezar Life Sciences

$25.47

-0.75 (-2.86%)

NERV

Minerva

$8.29

0.15 (1.84%)

CNMD

Conmed

$68.14

-0.1 (-0.15%)

KDMN

Kadmon

$2.46

-0.07 (-2.77%)

SLGL

Sol-Gel Technologies

$6.90

-0.2 (-2.82%)

JAZZ

Jazz Pharmaceuticals

$141.65

-9.05 (-6.01%)

LNTH

Lantheus

$15.70

0.35 (2.28%)

AUPH

Aurinia Pharmaceuticals

$5.17

-0.05 (-0.96%)

CRBP

Corbus Pharmaceuticals

$5.87

-0.49 (-7.70%)

CNCE

Concert Pharmaceuticals

$11.29

-0.505 (-4.28%)

SGMO

Sangamo

$9.50

-1.3 (-12.04%)

CNST

Constellation Pharmaceuticals

$5.83

0.025 (0.43%)

CTLT

Catalent

$37.90

-0.34 (-0.89%)

URGN

UroGen Pharma

$47.81

1.48 (3.19%)

ARRY

Array BioPharma

$14.53

-0.18 (-1.22%)

WST

West Pharmaceutical

$106.46

-0.37 (-0.35%)

RUBY

Rubius Therapeutics

$18.47

0.71 (4.00%)

CARA

Cara Therapeutics

$18.12

-0.8 (-4.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 27

    Nov

  • 01

    Dec

  • 03

    Dec

  • 20

    Dec

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Scotiabank to hold a conference »

Scotiabank Energy…

T

AT&T

$30.52

0.19 (0.63%)

, VZ

Verizon

$58.95

0.28 (0.48%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Morgan Stanley to hold a conference »

European Tech, Media…

T

AT&T

$30.52

0.19 (0.63%)

VZ

Verizon

$58.95

0.28 (0.48%)

LBTYA

Liberty Global

$24.27

0.6 (2.53%)

DISCA

Discovery

$31.92

-0.19 (-0.59%)

CCI

Crown Castle

$110.31

-0.39 (-0.35%)

TMUS

T-Mobile

$68.16

-0.29 (-0.42%)

ZAYO

Zayo Group

$23.20

-0.85 (-3.53%)

ERIC

Ericsson

$8.48

-0.44 (-4.93%)

SCMN

Swisscom

$0.00

(0.00%)

ASML

ASML

$172.78

1.78 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

MMM

3M

$197.98

-0.42 (-0.21%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
3M to host investor day »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BHVN

Biohaven Pharmaceutical

$33.70

-3.18 (-8.62%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Biohaven Pharmaceutical management to meet with Morgan Stanley »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 27

    Nov

GNBC

Green Bancorp

$18.18

-0.25 (-1.36%)

, VBTX

Veritex

$22.94

-0.24 (-1.04%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Green Bancorp to host special shareholder meeting »

Special Shareholder…

GNBC

Green Bancorp

$18.18

-0.25 (-1.36%)

VBTX

Veritex

$22.94

-0.24 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
RBC Capital U.S. Internet analyst to hold a group luncheon »

U.S. Internet Analyst…

ENPH

Enphase Energy

$5.40

-0.05 (-0.92%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Enphase Energy management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Morgan Stanley to hold a field trip »

2018 Middle East Energy…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.